Globus Medical
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +18.6% | +11.2% | +16.3% | +20.6% | +17.8% | +9.6% | +16.5% | +6.1% | +145.0% | +3.3% | +1.0% | |
| – | +15.9% | -5.7% | +20.7% | +1.7% | +9.0% | +19.5% | +5.2% | +13.7% | +94.8% | +13.7% | -2.4% | |
| – | -26.9% | +11.3% | +77.5% | +17.6% | +40.1% | +22.3% | -19.4% | -22.1% | +210.6% | +67.9% | -32.9% | |
| – | +22.9% | +3.3% | +28.7% | -9.1% | -8.3% | +37.0% | +3.9% | +0.6% | +16.1% | +71.9% | -37.4% | |
| – | +6.3% | +10.9% | +32.7% | +13.6% | +12.5% | -8.8% | +11.9% | +31.2% | +132.3% | +14.6% | +28.6% | |
| – | +15.7% | +7.1% | -3.8% | +21.1% | +49.6% | +16.7% | +3.4% | +26.2% | +183.7% | -22.3% | +15.2% | |
| – | +65.2% | +8.3% | +15.2% | +20.1% | +17.7% | +7.2% | +1.9% | +10.2% | – | – | – | |
| – | +72.9% | +15.2% | +17.0% | -0.1% | +4.1% | +21.7% | +14.7% | +9.9% | +626.5% | -0.2% | +0.2% | |
| – | -3.7% | +85.6% | +27.5% | +11.0% | -9.7% | +10.3% | -21.0% | -7.4% | +1,354.4% | -14.0% | -6.3% | |
| – | +0.6% | -19.5% | +15.9% | +4.0% | +12.6% | +33.6% | +24.6% | +6.4% | +373.6% | -1.3% | -32.1% | |
| – | -7.5% | -3.4% | +16.5% | +3.3% | +15.9% | +8.4% | +16.0% | +13.6% | +146.4% | +118.2% | -41.8% | |
| – | – | – | – | – | +1,555.4% | +18.8% | +6.5% | -97.3% | +371.9% | +3,690.4% | -96.8% | |
| – | -24.9% | +9.4% | +43.3% | +3.4% | -4.9% | -26.0% | +20.6% | +64.4% | +57.0% | +32.6% | +31.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +22.2% | +16.3% | +16.3% | +22.5% | +18.3% | +7.4% | +15.6% | +6.0% | +116.5% | +4.5% | +9.5% | |
| – | +27.4% | +19.9% | +17.1% | +21.3% | +17.4% | -0.3% | +14.3% | +3.8% | -8.3% | +1.4% | +20.4% | |
| – | +0.6% | +0.4% | +1.5% | +3.5% | +0.7% | -1.0% | +2.6% | -0.9% | +11.7% | +20.3% | -0.5% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.